With Kenyans mired in the COVID-19 pandemic, it is perhaps not surprising that value sales of consumer health products are set to rise in 2020 at a rate higher than those recorded during the review period. Broadly, a pandemic-inspired heightened focus on maintaining/improving health is driving greater interest in over the counter (OTC) health...
Consumer health is expected to see increased current value growth in 2020. The spread of the COVID-19 pandemic has fuelled growth of immunity-boosting vitamins and dietary supplements, as well as topical germicidals/antiseptics in the year. Sleep aids have also benefited from increased levels of stress and anxiety as a result of COVID-19,...
The outbreak of Coronavirus (COVID-19) has provided a shock to both the Spanish economy and society and significantly impacted consumer health sales. While Spain has not suffered from obvious shortages of medicines, the stockpiling of certain products, especially analgesics and cough, cold and allergy (hay fever) remedies, has been observed. Consumer...
To mitigate the risk of contracting COVID-19 consumers in Japan have been confining themselves to their homes on a more regular basis, while they are also taking a more proactive approach to their health, focusing on prevention over treatment. This has resulted in contrasting fortunes for the various product categories within consumer health....
The emergence of the pandemic in Colombia and subsequent lockdown by the government in an attempt to control the spread of the virus resulted in rising unemployment and decreasing disposable incomes, and led to many local consumers prioritising their spending on essential purchases, including groceries and medicines. Consumer health therefore,...
Consumer health has seen slightly higher growth overall in current value terms in 2020 compared to the previous year. Nevertheless, growth has remained largely in line with the review period average, with economic pressures preventing any more significant gains. When COVID-19 first appeared in South Africa there was some initial stockpiling...
COVID-19 had a significant impact on consumer health in Austria in 2020 with it resulting in consumers reassessing their priorities and focusing on their immediate concerns. As concerns rose about the threat posed by COVID-19 many households started stocking up on products that were perceived to treat the symptoms of the virus, such as analgesics...
In response to COVID-19 the Swiss government introduced a range of measures to limit the spread of the virus, with this having a mixed impact on the various categories of consumer health. Nonetheless, there was an overall improvement seen in 2020, spurred on by stronger sales in key categories including analgesics, cough, cold and allergy...
Consumer health is expected to see varied effects across a number of product areas in 2020 as a result of the COVID-19 pandemic. Analgesics and cough, cold and allergy (hay fever) remedies are expected to see spikes in retail current value growth in 2020 because of consumer stockpiling. Demand for these product areas is expected to increase...
The impact of the 19 pandemic on sales of consumer health products in Saudi Arabia was not as pronounced as in many other countries for the simple reason that many OTC products in Saudi Arabia are covered by health insurance policies. This means that many people rarely, if ever purchase their OTC products at full price via normal retail channels. Consumer...